Detalhe da pesquisa
1.
First-in-class pyrido[2,3-d]pyrimidine-2,4(1H,3H)-diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights.
Arch Pharm (Weinheim)
; 355(4): e2100440, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35106845